Matches 1 - 50 out of 106 1 2 3 >


Match Document Document Title
8148107 High affinity human antibodies to human nerve growth factor  
A human antibody or antigen-binding fragment of an antibody which specifically binds human nerve growth factor (NGF) with KD of 5 pM or less, as measured by surface plasmon resonance, wherein the...
8105598 Human monoclonal antibodies that specifically bind IGF-II  
Disclosed herein are isolated monoclonal human antibodies that specifically binds insulin-like growth factor II (IGF-II) with an equilibrium dissociation constant (Kd) of 1 nM or less, wherein the...
8058418 Polynucleotides encoding heavy and light chains of antibodies to OPGL  
Compositions comprising polynucleotides encoding heavy and light chains of antibodies that interact with osteoprotegerin ligand (OPGL) are described. Methods of making such antibodies are described.
7998480 Human BNP immunospecific antibodies  
The present invention relates to antibodies that immunospecifically bind to human brain natriuretic peptide or a human brain natriuretic peptide fragment with a high binding affinity, methods for...
7939077 Humanized antibody against fibroblast growth factor-8 and antibody fragment thereof  
The present invention relates to an antibody against FGF-8, particularly a humanized antibody against FGF-8 and the antibody fragment thereof, a DNA sequence encoding the above antibody or the...
7939069 Human BNP immunospecific antibodies  
The present invention relates to antibodies that immunospecifically bind to human brain natriuretic peptide or a human brain natriuretic peptide fragment with a high binding affinity, methods for...
7915004 Monoclonal antibodies, hybridomas, improved method for determining the protein PTX3 and kit for said determination  
Method for determining the level of PTX3 protein in a sample of a biological fluid; hybridoma capable of producing a rat anti-PTX3 monoclonal antibody where said hybridoma is selected from the...
7888485 Anti-pleiotrophin antibodies and methods of use thereof  
The present invention concerns antibodies that neutralize at least one biological activity of pleiotrophin. The antibodies can inhibit cancer cell growth and angiogenesis in vitro or in vivo. The...
7879322 Compositions and methods for use for antibodies against sclerostin  
The present invention relates to antibodies against sclerostin and compositions and methods of use for said antibodies to treat disease related to bone abnormalities such as osteoporosis. An...
7867725 Monoclonal antibodies against osteopontin  
The present invention relates to reagents and methods for the detection of osteopontin fragments and distinguishing them from each other and from the full-length osteopontin protein. The present...
7838245 Use of precursors of tachykinins and/or their fragments in medical diagnostic  
The present invention relates to the use of protachykinin and/or fragments thereof that can be isolated from body fluids, tissues or other bioiological samples and therefore, serves as a marker...
7829293 Antibodies to chemokine β-15  
The present invention concerns a member of the human chemokine CC protein family. In particular, isolated nucleic acid molecules are provided encoding the chemokine β-15 protein. Chemokine β-15 p...
7824681 Human monoclonal antibodies that specifically bind IGF-II  
Disclosed herein are isolated monoclonal human antibodies that specifically binds insulin-like growth factor II (IGF-II) with an equilibrium dissociation constant (Kd) of 1 nM or less, wherein the...
7811770 Method of detecting a subfraction of proBNP  
The present invention relates to antibodies specifically binding to native proBNP, a method for specific detection of native proBNP, a method of correlating the level of native proBNP to the...
7807380 Method of detecting a subfraction of proBNP  
The present invention relates to antibodies specifically binding to native proBNP, a method for specific detection of native proBNP, a method of correlating the level of native proBNP to the...
7795202 Methods for treating a neurological disorder by peripheral administration of a transforming growth factor alpha (TGF-a)  
The invention provides methods of treating a subject having a disease, disorder or condition of the central nervous system. The methods include administering TGF-α polypeptides, related ...
7790669 Methods for treating neurological deficits by intrastriatal administration of transforming growth factor alpha (TGF-α)  
The present invention features methods and compositions for treating a patient who has a neurological deficit. The method can be carried out, for example, by contacting (in vivo or in culture) a...
7691979 Anti-metastin antibody and its use  
The present invention aims at providing an antibody, by which metastin or its derivative can be quantified specifically with a high sensitivity, a method of detecting/quantifying metastin or its...
7534580 PSP94 diagnostic reagents and assays  
In the serum, PSP94 occurs as a free form or is associated with a carrier protein. PSP94 in its bound form has been quantified in the blood of prostate cancer patients and these measurements have...
7527939 Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP  
A specific and sensitive in vitro ELISA assay and diagnostic test kit is disclosed for determining levels of NT-proBNP protein in a variety of bodily fluids, non-limiting examples of which are...
7511123 Immuno-interactive fragments of the alpha-C subunit of inhibin  
Novels immuno-interactive fragments of the (alpha)C portion of a mammalian inhibin alpha subunit are disclosed, together with their variants and derivatives for producing antigen-binding molecules...
7507550 Analytical sandwich test for determining NT-proBNP  
The present invention concerns an immunological test for determining NT-proBNP comprising at least two antibodies to NT-proBNP, wherein at least one of the antibodies to NT-proBNP is a monoclonal...
7429483 Use of nerve growth factor for the storage, culture or treatment of cornea  
The nerve growth factor (NGF) is used for the storage of corneas in culture, for the production and the storage in vitro of single cell populations of the corneal morphological and functional unit...
7393655 Methods of identifying melanin concentrating hormone receptor antagonists  
This invention provides an isolated nucleic acid encoding a human MCH1 receptor, a purified human MCH1 receptor, vectors comprising isolated nucleic acid encoding a human MCH1 receptor, cells...
7312089 Detection of erythropoietin and erythropoietin receptor  
The invention is based on the development of several sensitive and simple methods for detecting erythropoietin and the erythropoietin receptor and associated antibodies. The methods and reagents...
7294706 Identification of receptor and heparin binding sites in FGF4 by structure-based mutagenesis  
The present invention provides methods and compositions that may be used to modulate binding of a fibroblast growth factor (FGF) polypeptide to an FGF receptor (FGFR). In preferred embodiments, the...
7264939 Method of detecting native proBNP  
The present invention relates to antibodies specifically binding to native proBNP, a method for specific detection of native proBNP, a method of correlating the level of native proBNP to the...
7227004 Antibodies to vascular endothelial cell growth factor  
The present invention provides monoclonal antibodies, and portions thereof, which are capable of specifically binding to human vascular endothelial cell growth factor (hVEGF) or hVEGF-related...
7112662 Anti-metasin antibodies and their methods of use  
The present invention aims at providing an antibody, by which metastin or its derivative can be quantified specifically with a high sensitivity, a method of detecting/quantifying metastin or its...
7079675 Histological assessment  
A method of measuring oestrogen or progesterone receptor (ER or PR) comprises identifying in histopathological specimen image data pixel groups indicating cell nuclei, and deriving image hue and...
7015023 Compositions and methods for detection of active proteases  
A novel assay system is disclosed for detecting the presence or amount of selected active proteases in biological samples. The assay system utilizes a chimeric protease detector protein composed of...
7014847 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders  
The present invention pertains to methods for preventing reovirus recognition in the treatment of cellular proliferative disorders, and particularly ras-mediated cellular proliferative disorders,...
6960472 Monoclonal antibodies against N-Terminus proBNP  
Monoclonal antibodies having high affinity for N-terminus pro brain natriuretic peptide (NT-proBNP) are described. The monoclonal antibodies are prepared against a synthetic peptide having the...
6949380 Transdifferentiation of epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells  
Disclosed is a method of transdifferentiating an epidermal basal cell into a cell having one or more morphological, physiological and/or immunological features of a neural progenitor, neuronal, or...
6929924 C-peptide specific assay procedure  
The present invention relates to a specific C-peptide assay method which can eliminate all interference due to proinsulin and its intermediates, in particular des-31,32-proinsulin and/or...
6814967 Antibodies to cortistatin: neuropeptides, compositions and methods  
The present invention relates generally to nucleic acids encoding a novel neuropeptide designated cortistatin. The cortistatin nucleic acids, proteins and polypeptides thereof along with...
6767721 Flea ecdysone nucleic acid molecules and uses thereof  
The present invention relates to flea ecdysone receptor and ultraspiracle proteins; to flea ecdysone receptor and ultraspiracle nucleic acid molecules, including those that encode such flea...
6716594 Monoclonal antibody  
The invention relates to monoclonal antibody capable of specific binding to the molecular weight of 20 kDa variant of human growth hormone. This monoclonal antibody has no substantial binding to...
6680373 P2U2 receptor antibodies  
A novel subtype of the P2-purinergic receptor, referred to as the P2U2 receptor, is disclosed. This receptor is activated by four of its agonists in the following order of specificity:...
6677124 Monoclonal antibody recognizing C-terminus of hBNP  
A hybridoma producing a monoclonal antibody recognizing the C-terminus of human brain natriuretic peptide (hBNP) was cultivated in a medium or the abdominal cavity of a mouse to recover the...
6413726 Antibodies that specifically bind Cytostatin III  
The invention relates to Cytostatin III polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and...
6339143 Methods of using antibodies against hormone-related determinants  
This invention provides methods for detecting the presence of human malignant cells in a sample of tumor cells; determining whether a tumor present in a human subject is malignant; obtaining an...
6248546 Assay of IGFBP complex  
A method of assaying the growth hormone status of an individual by immuno-assay for the 150 KDa Insulin-like Growth Factor ternary complex (IGF/IGFBP-3/ALS). Alternatively, a binary complex may be...
6235490 Immunoassay of human growth hormone with a molecular weight of about 20,000  
An animal cell capable of producing an antibody specific to a human growth hormone having a molecular weight of 20,000 (20 k hGH) was prepared from an animal immunized with 20 k hGH. The animal...
6197938 Monoclonal antibody specific for 20K human growth hormone and a cell line producing the monoclonal antibody  
An animal cell capable of producing an antibody specific to a human growth hormone having a molecular weight of 20,000 (20 k hGH) was prepared from an animal immunized with 20 k hGH. The animal...
6183971 Human betacellulin-specific antibodies and uses thereof  
Disclosed are an antibody which have a binding activity to human betacellulin protein or a mutein thereof with specificity; especially a monoclonal antibody which does not have cross reactitivity...
6162902 Human BNP-specific antibodies  
The present invention provides reagents and assays for the quantification of hBNP in biological fluid samples such as plasma or serum. Antibodies are provided which are monospecific to epitopes...
6124439 OB polypeptide antibodies and method of making  
The present invention relates generally to the control of body weight of animals including mammals and humans, and more particularly to materials identified herein as modulators of body weight, and...
6043086 Neurotactin and uses therefor  
The present invention relates to the identification and characterization of a novel, membrane-anchored chemokine, neurotactin. Sequence analysis of neurotactin reveals that, while it includes an...
6025143 Antibodies directed against peptides derived from the SMR1 polypeptide  
The present invention relates to peptides and polypeptides derived from the submaxillary gland of the rat. In particular, the present invention discloses a purified peptide of formuls:...
Matches 1 - 50 out of 106 1 2 3 >